Nasus Pharma is trading 7.5% up at $3.44, with no clear catalyst identified.
- The stock closed at $3.20 on August 13, 2026.
- No company-specific announcement, filing, earnings release, analyst action, or other direct catalyst has been identified for August 14, 2026.
- Broader markets are modestly lower, with the Nasdaq Composite down 0.51%; the rally’s cause remains unclear.